A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

EyeXam and GenieMD Announce Mobile Collaboration in Eye Care

EyeXam, the industry’s leading and patented mobile app, and GenieMD, a global provider of telemedicine solutions offering an accessible platform for connecting patients and providers around the world, today announced a joint venture introducing eyeXamVirtual, to modernize the eye care industry with an accessible and best-in-class telemedicine mobile solution.

Together, GenieMD and EyeXam’s resources will enable consumers easy access to eye care providers physically and virtually. GenieMD’s mission is to democratize health care globally, and this partnership will elevate eye care into a new era of telehealth engagement. Consumers will benefit from unprecedented and effortless access to eye care and doctor engagement, resulting in superior eye health. The venture partners GenieMD’s innovative telemedicine platform with EyeXam’s proprietary and self-guided method for measuring visual acuity using a mobile device. The impact of this partnership will create an unparalleled and proactive eye care solution, leading to a better overall eye health experience for consumers.

“We are excited to team up with EyeXam,” said Soheil Saadat, Ph.D., GenieMD’s founder, and CEO, “to deliver a unique telemedicine engagement model to vision care by combining EyeXam’s patented technology with our world-class cloud computing, big data, artificial intelligence and mobile technologies to provide the finest and fastest access to eye care patients, when they need it most.”

“We are grateful to partner with GenieMD,” Nikki Iravani, OD, optometrist and EyeXam founder and CEO commented, “to optimize the existing EyeXam app and bring the best in class in telemedicine to eye care. COVID-19 presented challenging circumstances and increased the demand for patients to visit with eye care providers virtually. EyeXam’s infrastructure and patented technology together with GenieMD’s platform accelerated the availability of virtual eye care for our patients.”

About GenieMD

SourceEyeXam™
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy